Fibrinet
Biological
Royal Biologics
Total Payments
$332,356
Transactions
705
Doctors
212
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $89,355 | 50 | 14 |
| 2023 | $54,090 | 47 | 13 |
| 2022 | $38,177 | 123 | 74 |
| 2021 | $77,341 | 254 | 116 |
| 2020 | $28,045 | 95 | 50 |
| 2019 | $45,348 | 136 | 39 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $203,946 | 164 | 61.4% |
| Unspecified | $62,512 | 10 | 18.8% |
| Food and Beverage | $40,750 | 476 | 12.3% |
| Royalty or License | $19,795 | 48 | 6.0% |
| Travel and Lodging | $3,352 | 6 | 1.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,000 | 1 | 0.6% |
Payments by Type
General
$269,844
695 transactions
Research
$62,512
10 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Platelet Rich Fibrin Matrix in ACDF Surgery: Is it an effective bone grafting option used alone? | Royal Biologics, Inc. | $50,929 | 0 |
| Foot & Ankle Fusion Case Series | Royal Biologics, Inc. | $7,250 | 1 |
| PILOT STUDY TO EVALUATE THE EFFECTS OF PLATELET RICH FIBRIN MATRIX (FIBRINET) ON DIABETIC FOOT ULCERS | Royal Biologics, Inc. | $3,085 | 0 |
| PILOT STUDY TO EVALUATE THE EFFECTS OF PLATELET RICH FIBRIN MATRIX FIBRINET ON DIABETIC FOOT ULCERS | Royal Biologics, Inc. | $1,248 | 1 |
Top Doctors Receiving Payments for Fibrinet
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Princeton, NJ | $54,014 | 5 |
| , DPM | Sports Medicine | Brooklyn, NY | $22,496 | 43 |
| , M.D | Student in an Organized Health Care Education/Training Program | Daphne, AL | $17,261 | 21 |
| , MD | Orthopaedic Surgery | Shelton, CT | $15,349 | 21 |
| , DPM | Foot Surgery | Mamaroneck, NY | $14,233 | 11 |
| , M.D | Neurological Surgery | Washington, DC | $13,675 | 16 |
| , M.D | Neurological Surgery | New London, CT | $13,178 | 21 |
| , MD | Orthopaedic Surgery | Easton, PA | $10,569 | 1 |
| , DPM | Podiatrist | Fresno, CA | $10,537 | 1 |
| , DO | Plastic Surgery | Morristown, NJ | $10,200 | 4 |
| , MD | Orthopaedic Surgery | Rochester, MN | $8,312 | 10 |
| , DPM | Foot & Ankle Surgery | New York, NY | $7,679 | 20 |
| , MD | Neurological Surgery | Union, NJ | $7,664 | 14 |
| , DPM | Foot & Ankle Surgery | New York, NY | $7,448 | 20 |
| , MD | Sports Medicine | Birmingham, AL | $7,150 | 5 |
| , M.D | Orthopaedic Surgery | Washington, DC | $6,925 | 13 |
| , D.P.M | Podiatrist | Brooklyn, NY | $6,373 | 19 |
| , D.P.M | Foot & Ankle Surgery | Fort Lee, NJ | $6,124 | 14 |
| Craig Radnay | Orthopaedic Surgery | New York, NY | $5,957 | 10 |
| , MD | Orthopaedic Surgery of the Spine | East Syracuse, NY | $5,144 | 10 |
| , MD | Student in an Organized Health Care Education/Training Program | Westbury, NY | $4,672 | 11 |
| , D.P.M | Foot & Ankle Surgery | Garden City Park, NY | $4,304 | 14 |
| , D.P.M | Foot & Ankle Surgery | Fullerton, CA | $3,900 | 3 |
| , M. D | Foot and Ankle Surgery | New York, NY | $3,847 | 19 |
| , DPM | Foot & Ankle Surgery | Brooklyn, NY | $3,564 | 8 |
Ad
Manufacturing Companies
- Royal Biologics, Inc. $258,963
- Royal Biologics $73,393
Product Information
- Type Biological
- Total Payments $332,356
- Total Doctors 212
- Transactions 705
About Fibrinet
Fibrinet is a biological associated with $332,356 in payments to 212 healthcare providers, recorded across 705 transactions in the CMS Open Payments database. The primary manufacturer is Royal Biologics.
Payment data is available from 2019 to 2024. In 2024, $89,355 was paid across 50 transactions to 14 doctors.
The most common payment nature for Fibrinet is "Consulting Fee" ($203,946, 61.4% of total).
Fibrinet is associated with 4 research studies, including "Platelet Rich Fibrin Matrix in ACDF Surgery: Is it an effective bone grafting option used alone?" ($50,929).